AAAAAA
Results:
1-22
|
Results: 22
Authors:
Fleischhack, G
Schmidt-Niemann, M
Wulff, B
Havers, W
Marklein, G
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients, SUPP CARE C, 9(5), 2001, pp. 372-379
Authors:
Fleischhack, G
Hartmann, C
Simon, A
Wulff, B
Havers, W
Marklein, G
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer, J ANTIMICRO, 47(6), 2001, pp. 841-853
Authors:
Creutzig, U
Berthold, F
Boos, J
Fleischhack, G
Gadner, H
Gnekow, A
Graubner, U
Henze, G
Hermann, J
Imbach, P
Jurgens, H
Kabisch, H
Korholz, D
Niemeyer, CM
Reinhardt, D
Reiter, A
Ritter, J
Spaar, HJ
Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
Authors:
Fleischhack, G
Simon, A
Citation: G. Fleischhack et A. Simon, Importance of prevention of infectious complications in pediatric hematologic-oncologic patients., KLIN PADIAT, 213, 2001, pp. A5-A8
Authors:
Simon, A
Fleischhack, G
Citation: A. Simon et G. Fleischhack, Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients., KLIN PADIAT, 213, 2001, pp. A9-A21
Authors:
Simon, A
Fleischhack, G
Marklein, G
Ritter, J
Citation: A. Simon et al., Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients., KLIN PADIAT, 213, 2001, pp. A22-A37
Authors:
Simon, A
Fleischhack, G
Citation: A. Simon et G. Fleischhack, Surveillance for nosocomial infections in pediatric hematology/oncology patients., KLIN PADIAT, 213, 2001, pp. A106-A113
Authors:
Utsch, B
Fleischhack, G
Knopfle, G
Hasan, C
Bode, U
Citation: B. Utsch et al., Immature gastric teratoma of the lesser curvature in a male infant, J PED GASTR, 32(2), 2001, pp. 204-206
Authors:
Fleischhack, G
Kambeck, I
Cipic, D
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Interpretation of inflammatory markers in feverish cancer patients with orwithout neutropenia at admission - Reply, BR J HAEM, 114(2), 2001, pp. 490-491
Authors:
Fleischhack, G
Reif, S
Hasan, C
Jaehde, U
Hettmer, S
Bode, U
Citation: G. Fleischhack et al., Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours, BR J CANC, 84(11), 2001, pp. 1453-1459
Authors:
Fleischhack, G
Hassan, C
Graf, N
Mann, G
Bode, U
Citation: G. Fleischhack et al., IDA-FLAG - An effective reinduction therapy for poor prognosis AML of childhood - Report of a multicenter phase II trial, HEMAT BLOOD, 40, 2001, pp. 544-552
Authors:
Simon, A
Fleischhack, G
Hasan, C
Bode, U
Engelhart, S
Kramer, MH
Citation: A. Simon et al., Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients, INFECT CONT, 21(9), 2000, pp. 592-596
Authors:
Kusch, M
Labouvie, H
Ladisch, V
Fleischhack, G
Bode, U
Citation: M. Kusch et al., Structuring psychosocial care in pediatric oncology, PAT EDUC C, 40(3), 2000, pp. 231-245
Authors:
Fleischhack, G
Cipic, D
Juettner, J
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Procalcitonin - a sensitive inflammation marker of febrile episodes in neutropenic children with cancer, INTEN CAR M, 26, 2000, pp. S202-S211
Authors:
Fleischhack, G
Kambeck, I
Cipic, D
Hasan, C
Bode, U
Citation: G. Fleischhack et al., Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II, BR J HAEM, 111(4), 2000, pp. 1093-1102
Authors:
Utsch, B
Fleischhack, G
Hasan, C
Bode, U
Citation: B. Utsch et al., Nephrotic syndrome as paraneoplastic syndrome of Hodgkin Disease, EUR J PED, 158(9), 1999, pp. 768-768
Authors:
Wermes, C
Fleischhack, G
Junker, R
Schobess, R
Schwabe, D
Sykora, KW
Nowak-Gottl, U
Citation: C. Wermes et al., Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors, KLIN PADIAT, 211(4), 1999, pp. 211-214
Authors:
Bode, U
Hasan, C
Hulsmann, B
Fleischhack, G
Citation: U. Bode et al., Recancostat compositum (R) therapy does not prevent tumor progression in young cancer patients, KLIN PADIAT, 211(4), 1999, pp. 353-355
Authors:
Zernikow, B
Michel, E
Fleischhack, G
Bode, U
Citation: B. Zernikow et al., Accidental iatrogenic intoxications by cytotoxic drugs - Error analysis and practical preventive strategies, DRUG SAFETY, 21(1), 1999, pp. 57-74
Authors:
Pinheiro, JPV
Ahlke, E
Nowak-Gottl, U
Hempel, G
Muller, HJ
Lumkemann, K
Schrappe, M
Rath, B
Fleischhack, G
Mann, C
Boos, J
Citation: Jpv. Pinheiro et al., Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols, BR J HAEM, 104(2), 1999, pp. 313-320
Authors:
Fleischhack, G
Citation: G. Fleischhack, Treatment of relapsed AML in children, BR J HAEM, 104(2), 1999, pp. 420-421
Authors:
Nowak-Gottl, U
Wermes, C
Junker, R
Koch, HG
Schobess, R
Fleischhack, G
Schwabe, D
Ehrenforth, S
Citation: U. Nowak-gottl et al., Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors, BLOOD, 93(5), 1999, pp. 1595-1599
Risultati:
1-22
|